Last Placement

RECCE PHARMACEUTICALS LTD

Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of antibiotics.

RCE's portfolio of antibiotic therapies seek to address health threats posed by drug resistant bacteria. Their lead candidate RECCE®327 is designed as abroad-spectrum antibiotic, formulated using synthetic polymer technology to treat bacterial sepsis (blood poisoning) and other bacterial infections, including superbugs.

Announcements

Market Data

Company

Support

Archive

Features

Contact Us

announcement

Rows per page: 0-0 of 0